Real-World study shows rybelsus lowers blood sugar in type 2 diabetes
NCT ID NCT05230615
First seen Nov 01, 2025 · Last updated Jun 17, 2026 · Updated 35 times
Summary
This study looked at how well Rybelsus (oral semaglutide) works for adults with type 2 diabetes in Italy. Researchers tracked blood sugar levels and weight changes over 8-10 months in 458 people already prescribed the drug by their doctor. The goal was to see if the medicine helps control diabetes in real-world settings, not just in controlled trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
IRCCS MultiMedica
Sesto San Giovanni, Italy
-
Master Centre for Italy
Rome, 00144, Italy
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.